Neuroscience

Neurons
#Bipolar #Neuroscience #Psychiatry #Society for Neuroscience #Walsh Research Institute

Breakthroughs in bipolar disorder announced at Neuroscience 2024

A Walsh Research Institute scientist presented an advanced theory of bipolar disorder at the annual meeting of the Society for Neuroscience, Neuroscience 2024. After a multi-year investigation of recent neuroscience advances, Dr William Walsh believes he has resolved many unknowns that have puzzled researchers for a… Read More

#News #Trending News

Pluripotent stem cells
#Cell therapy #Neuroscience #Pluripotent stem cells #Society for Neuroscience #Stem cells

Neuroscience 2024: Leveraging human stem cells to treat diseases

Progress in stem cell technologies is advancing powerful new ways of studying and treating formerly intractable neurological and neuropsychiatric diseases. Several interwoven examples have been discussed at Neuroscience 2024, the annual meeting of the Society for Neuroscience. Over 40% of the global population lives with some… Read More

#News #Trending News

Ozempic Insulin injection pen
#Diabetes #GLP-1 #Neuroscience #Obesity #Society for Neuroscience #Weight loss

News from SfN’s Neuroscience 2024: The brain on GLP-1 agonists

Diabetes and weight loss drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists have widespread effects in the brain, with new research presented at the Society for Neuroscience’s Neuroscience 2024 uncovering potential novel therapeutic benefits and behavioural side effects. About one in eight adults… Read More

#News #Trending News

Neurons in the brain
#Events #Lab technology #Neuroscience #Webinar

DDW Neuroscience Showcase presentation announcement

In this free online event at 3pm BST on 24 October, hosted by DDW and co-sponsored by ApconiX and AxoSim, leading industry figures will outline the areas of opportunity and challenges in the neuroscience drug discovery & development sector. The showcase will include… Read More

#News

Neurons
#Ageing #CRISPR #Gene editing #Neuroscience #Regenerative Medicine #Stanford University

CRISPR gene editing reduces brain function decline with age

A new study has revealed that reducing the activity of a particular gene using CRISPR gene editing can rejuvenate stem cells in the brain to create fresh neurons. The finding in mice could open new avenues for potential therapeutics to improve brain function and reduce regenerative… Read More

#Editor's Choice #News

#Cystic fibrosis #Financing #Funding #Neuroscience #Oncology #Rare disease

This week in drug discovery (30 Sept – 4 Oct) 

News round-up for 30 Sept – 4 Oct by DDW Senior Digital Content Editor Diana Spencer. The theme of the news highlights this week is funding, with companies raising considerable levels of private investment, alongside new funding grants to advance the development of therapeutics for lung infections in… Read More

#News

#Amyotrophic lateral sclerosis (ALS) #CNS #Drug discovery #Neuroscience

The latest advancements driving neuroscience drug discovery research

In this webinar, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Dr Klein shares how Dewpoint applies insights into… Read More

Webinar date:
Supported by Apconix
#Webinars

#Events #Neuroscience #Society for Neuroscience

Looking forward to SfN’s Neuroscience 2024

Ahead of the Society for Neuroscience's (SfN) Neuroscience 2024 in Chicago, US from 5-9 October, DDW’s Megan Thomas, speaks to SfN President Dr Marina Picciotto, and looks at what we can expect from this annual global neuroscience event.  SfN perspective Dr Marina Picciotto reflects that the SfN annual meeting started… Read More

#Exclusive Content

#Drug development #Drug discovery #Drug technology #Neuroscience #Webinar

Watch DDW’s first Neuroscience Showcase

In this free online event at 3pm BST on 24 October, hosted by DDW and sponsored by ApconiX and AxoSim, leading industry figures outline the areas of opportunity and challenges in the neuroscience drug discovery & development sector. The showcase includes a panel… Read More

Webinar date:
Co-sponsored by ApconiX and AxoSim
#News

#Drug development #Drug discovery #Drug technology #Neuroscience

Neuroscience Showcase

In this free online event, hosted by DDW and sponsored by ApconiX and AxoSim, leading industry figures will outline the areas of opportunity and challenges in the neuroscience drug discovery & development sector. The showcase will include a panel discussion looking at the use of new drug discovery and development… Read More

Webinar date:
Sponsored by ApconiX and AxoSim
#Webinars

Neuroscience innovation
#Amyotrophic lateral sclerosis (ALS) #CNS #Drug development #Drug discovery #Neuroscience #Webinar

Last chance: Driving neuroscience drug discovery research

In this webinar on 30 September, from 3-4PM BST, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Read More

#News

Brain inflammation
#Bristol Myers Squibb #FDA #Neuroscience #PureTech #Schizophrenia

New approach to schizophrenia treatment secures US approval

The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care. “Schizophrenia… Read More

#News #Regulatory #Trending News

#CAR-T #Cell therapy #Immunotherapy #Neurodegenerative disorders #Neuroscience #Oncology

New DDW Highlights vodcast: 24 September 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   This week we have seen… Read More

#News

#CAR-T #Cell therapy #Immunotherapy #Neurodegenerative disorders #Neuroscience #Oncology

New DDW Highlights podcast: 23 September 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week we have seen a number of developments related to cell therapies, particularly… Read More

#News

#Amyotrophic lateral sclerosis (ALS) #CNS #Drug development #Drug discovery #Neuroscience #Webinar

What are the latest advancements driving neuroscience drug discovery?

In this webinar on 30 September, from 3-4PM BST, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Read More

#News